# KKR Biosimilar L.P.: insider transactions

SEC CIK 1624314. Roles and transactions as reported on Form 4. Latest Form 4 filed 2014-11-14.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Coherus Oncology, Inc.](/companies/chrs.md) | 10% owner | 2 | 2014-11-12 | 2014-11-12 |

## Transactions: 2

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2014-11-12 | [Coherus Oncology, Inc.](/companies/chrs.md) | Conversion (C), derivative | 2,499,499 | $0.00 | $0 | [Form 4](/filings/0001104659-14-080993.md) |
| 2014-11-12 | [Coherus Oncology, Inc.](/companies/chrs.md) | Conversion (C) | 2,499,499 | not reported | not reported | [Form 4](/filings/0001104659-14-080993.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 12:50 ET. No prices; not investment advice.